Glaukos GKOS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Glaukos (GKOS) Core Market Data and Business Metrics
Latest Closing Price
$100.04Price-Earnings Ratio
-36.12Total Outstanding Shares
56.57 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
1 Glaukos Way, Aliso Viejo, CA, 92656
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,340,260 Shares | 2.77 | 3/14/2025 | 3,715,518 Shares |
| 1,406,354 Shares | 2.51 | 2/28/2025 | 3,535,415 Shares |
| 509,132 Shares | 6.84 | 2/14/2025 | 3,483,366 Shares |
| 438,290 Shares | 7.66 | 1/31/2025 | 3,357,415 Shares |
| 669,654 Shares | 4.82 | 1/15/2025 | 3,226,602 Shares |
| 688,515 Shares | 4.41 | 12/31/2024 | 3,037,964 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $78.05 Million |
| Net Cash Flow From Operating Activities | $-61.32 Million |
| Net Cash Flow From Investing Activities, Continuing | $47.83 Million |
| Net Cash Flow | $78.05 Million |
| Net Cash Flow From Operating Activities, Continuing | $-61.32 Million |
| Net Cash Flow From Investing Activities | $47.83 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Earnings Per Share | $-2.77 |
| Basic Average Shares | $52.76 Million |
| Operating Income/Loss | $-122.37 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-146.37 Million |
| Selling, General, and Administrative Expenses | $261.17 Million |
| Nonoperating Income/Loss | $-23.23 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-144.92 Million |
| Other Comprehensive Income/Loss | $1.45 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $-144.92 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities | $207.82 Million |
| Equity | $766.93 Million |
| Current Assets | $449.79 Million |
| Other Current Assets | $392.11 Million |
| Liabilities And Equity | $974.76 Million |
| Intangible Assets | $263.44 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||